CG Oncology, Inc. Common stock
CGON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43,808 | -$41,426 | -$34,452 | -$31,798 |
| Dep. & Amort. | $416 | $156 | $24 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,331 | $7,007 | $5,151 | $4,990 |
| Change in WC | -$2,873 | $8,663 | $469 | $4,896 |
| Other Non-Cash | $40 | -$2,359 | -$469 | $1,250 |
| Operating Cash Flow | -$38,894 | -$27,959 | -$29,277 | -$20,662 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$97 | -$14 | -$16 | -$209 |
| Net Acquisitions | -$21,967 | $0 | $0 | $0 |
| Inv. Purchases | -$240,270 | -$167,960 | -$361,892 | -$217,068 |
| Inv. Sales/Matur. | $251,379 | $170,381 | $200,139 | $228,182 |
| Other Inv. Act. | $26,000 | -$1,000 | -$25,000 | $0 |
| Investing Cash Flow | $15,045 | $1,407 | -$186,769 | $10,905 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $365 |
| Stock Issued | $49,001 | -$296 | $450 | $223,059 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,369 | $0 | $0 | -$365 |
| Financing Cash Flow | $54,370 | -$296 | $450 | $223,414 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30,521 | -$26,848 | -$215,596 | $213,657 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,624 | $41,472 | $257,068 | $43,411 |
| End Cash | $45,145 | $14,624 | $41,472 | $257,068 |
| Free Cash Flow | -$38,991 | -$27,973 | -$29,293 | -$20,871 |